Tenax Therapeutics Stock Price History
| TENX Stock | USD 6.43 0.18 2.88% |
Below is the normalized historical share price chart for Tenax Therapeutics extending back to July 24, 1995. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Tenax Therapeutics stands at 6.43, as last reported on the 20th of March, with the highest price reaching 6.59 and the lowest price hitting 6.20 during the day.
If you're considering investing in Tenax Stock, it is important to understand the factors that can impact its price. Tenax Therapeutics appears to be slightly risky, given 3 months investment horizon. Tenax Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0761, which indicates the firm had a 0.0761 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Tenax Therapeutics, which you can use to evaluate the volatility of the company. Please review Tenax Therapeutics' Risk Adjusted Performance of 0.0419, coefficient of variation of 2582.13, and Semi Deviation of 3.51 to confirm if our risk estimates are consistent with your expectations.
At this time, Tenax Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 300 K in 2025, whereas Common Stock is likely to drop 25.65 in 2025. . At this time, Tenax Therapeutics' Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 0.64 in 2025, whereas Price Earnings Ratio is likely to drop (0.67) in 2025. Tenax Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 2nd of January 1997 | 200 Day MA 4.691 | 50 Day MA 6.421 | Beta 2.193 |
Tenax |
Sharpe Ratio = 0.0761
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TENX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.13 actual daily | 36 64% of assets are more volatile |
Expected Return
| 0.31 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 5 95% of assets perform better |
Based on monthly moving average Tenax Therapeutics is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tenax Therapeutics by adding it to a well-diversified portfolio.
Tenax Therapeutics Stock Price History Chart
There are several ways to analyze Tenax Stock price data. The simplest method is using a basic Tenax candlestick price chart, which shows Tenax Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 10, 2025 | 7.76 |
| Lowest Price | December 23, 2024 | 5.49 |
Tenax Therapeutics March 20, 2025 Stock Price Synopsis
Various analyses of Tenax Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Tenax Stock. It can be used to describe the percentage change in the price of Tenax Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Tenax Stock.| Tenax Therapeutics Price Rate Of Daily Change | 1.03 | |
| Tenax Therapeutics Price Action Indicator | 0.12 | |
| Tenax Therapeutics Price Daily Balance Of Power | 0.46 | |
| Tenax Therapeutics Accumulation Distribution | 274.12 |
Tenax Therapeutics March 20, 2025 Stock Price Analysis
Tenax Stock Price History Data
The price series of Tenax Therapeutics for the period between Fri, Dec 20, 2024 and Thu, Mar 20, 2025 has a statistical range of 2.27 with a coefficient of variation of 7.67. The price distribution for the period has arithmetic mean of 6.3. The median price for the last 90 days is 6.23. The company completed stock split (1:80) on 3rd of January 2024. Tenax Therapeutics had dividends distributed to its stock-holders on 2018-02-26.| Open | High | Low | Close | Volume | ||
| 03/19/2025 | 6.21 | 6.59 | 6.20 | 6.43 | 4,632 | |
| 03/18/2025 | 6.16 | 6.34 | 6.16 | 6.25 | 6,613 | |
| 03/17/2025 | 6.31 | 6.39 | 6.15 | 6.23 | 10,033 | |
| 03/14/2025 | 6.36 | 6.52 | 6.10 | 6.41 | 3,772 | |
| 03/13/2025 | 6.35 | 6.55 | 6.14 | 6.36 | 21,392 | |
| 03/12/2025 | 6.08 | 6.40 | 6.08 | 6.40 | 1,918 | |
| 03/11/2025 | 5.98 | 6.59 | 5.80 | 6.19 | 23,774 | |
| 03/10/2025 | 6.33 | 6.33 | 6.01 | 6.02 | 12,555 | |
| 03/07/2025 | 5.95 | 6.20 | 5.95 | 6.19 | 17,932 | |
| 03/06/2025 | 6.06 | 6.32 | 5.91 | 5.95 | 33,976 | |
| 03/05/2025 | 6.10 | 6.36 | 5.93 | 6.23 | 469,059 | |
| 03/04/2025 | 5.67 | 6.06 | 5.58 | 6.04 | 9,979 | |
| 03/03/2025 | 5.93 | 6.47 | 5.69 | 5.69 | 12,777 | |
| 02/28/2025 | 6.17 | 6.17 | 5.94 | 5.97 | 6,182 | |
| 02/27/2025 | 6.08 | 6.14 | 5.93 | 6.01 | 13,994 | |
| 02/26/2025 | 5.90 | 6.09 | 5.90 | 6.08 | 8,062 | |
| 02/25/2025 | 6.25 | 6.25 | 5.68 | 5.90 | 34,459 | |
| 02/24/2025 | 6.62 | 6.75 | 6.24 | 6.27 | 13,784 | |
| 02/21/2025 | 6.37 | 6.86 | 6.37 | 6.75 | 33,251 | |
| 02/20/2025 | 6.98 | 6.98 | 6.10 | 6.13 | 59,341 | |
| 02/19/2025 | 7.09 | 7.30 | 6.50 | 6.70 | 67,873 | |
| 02/18/2025 | 7.40 | 7.40 | 6.92 | 7.07 | 15,101 | |
| 02/14/2025 | 7.45 | 7.45 | 7.11 | 7.20 | 14,197 | |
| 02/13/2025 | 7.66 | 7.69 | 7.16 | 7.30 | 25,076 | |
| 02/12/2025 | 7.48 | 7.65 | 7.28 | 7.52 | 31,091 | |
| 02/11/2025 | 7.50 | 7.66 | 7.10 | 7.36 | 18,940 | |
| 02/10/2025 | 7.25 | 7.89 | 6.94 | 7.76 | 98,421 | |
| 02/07/2025 | 7.07 | 7.33 | 7.07 | 7.23 | 139,097 | |
| 02/06/2025 | 6.70 | 7.10 | 6.70 | 7.07 | 248,000 | |
| 02/05/2025 | 6.45 | 6.97 | 6.41 | 6.65 | 108,000 | |
| 02/04/2025 | 6.10 | 6.13 | 5.89 | 6.00 | 8,389 | |
| 02/03/2025 | 5.85 | 6.40 | 5.85 | 5.95 | 19,731 | |
| 01/31/2025 | 5.93 | 6.28 | 5.89 | 6.00 | 122,924 | |
| 01/30/2025 | 6.06 | 6.24 | 5.91 | 6.00 | 8,678 | |
| 01/29/2025 | 6.20 | 6.20 | 6.02 | 6.10 | 6,531 | |
| 01/28/2025 | 6.30 | 6.46 | 6.07 | 6.21 | 14,356 | |
| 01/27/2025 | 6.59 | 6.60 | 6.17 | 6.38 | 32,215 | |
| 01/24/2025 | 6.58 | 6.63 | 6.52 | 6.54 | 5,908 | |
| 01/23/2025 | 6.57 | 6.68 | 6.52 | 6.52 | 14,608 | |
| 01/22/2025 | 6.50 | 6.59 | 6.46 | 6.50 | 9,807 | |
| 01/21/2025 | 6.37 | 6.73 | 6.30 | 6.45 | 15,080 | |
| 01/17/2025 | 6.30 | 6.48 | 6.20 | 6.37 | 15,466 | |
| 01/16/2025 | 6.30 | 6.65 | 6.22 | 6.41 | 15,729 | |
| 01/15/2025 | 6.43 | 6.49 | 6.22 | 6.48 | 12,942 | |
| 01/14/2025 | 6.50 | 6.50 | 6.14 | 6.43 | 82,705 | |
| 01/13/2025 | 6.34 | 6.34 | 5.92 | 6.16 | 19,396 | |
| 01/10/2025 | 6.53 | 6.53 | 6.16 | 6.24 | 19,004 | |
| 01/08/2025 | 6.13 | 6.57 | 6.12 | 6.48 | 38,226 | |
| 01/07/2025 | 6.38 | 6.48 | 6.13 | 6.41 | 39,510 | |
| 01/06/2025 | 6.18 | 6.59 | 6.18 | 6.28 | 31,318 | |
| 01/03/2025 | 6.65 | 6.67 | 6.18 | 6.22 | 44,727 | |
| 01/02/2025 | 6.29 | 6.55 | 6.29 | 6.55 | 14,106 | |
| 12/31/2024 | 6.41 | 6.53 | 6.15 | 6.19 | 26,423 | |
| 12/30/2024 | 6.58 | 7.00 | 6.34 | 6.55 | 206,156 | |
| 12/27/2024 | 5.73 | 6.40 | 5.55 | 6.30 | 92,839 | |
| 12/26/2024 | 5.65 | 5.73 | 5.54 | 5.73 | 16,265 | |
| 12/24/2024 | 5.66 | 5.66 | 5.44 | 5.65 | 2,897 | |
| 12/23/2024 | 5.67 | 5.67 | 5.47 | 5.49 | 4,419 | |
| 12/20/2024 | 5.47 | 5.78 | 5.39 | 5.61 | 21,110 | |
| 12/19/2024 | 5.50 | 5.58 | 5.42 | 5.56 | 11,578 | |
| 12/18/2024 | 5.70 | 5.80 | 5.50 | 5.52 | 58,904 |
About Tenax Therapeutics Stock history
Tenax Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Tenax is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Tenax Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Tenax Therapeutics stock prices may prove useful in developing a viable investing in Tenax Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 285.7 K | 300 K | |
| Net Loss | -29.2 M | -27.8 M |
Tenax Therapeutics Quarterly Net Working Capital |
|
Tenax Therapeutics Stock Technical Analysis
Tenax Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Money Flow Index Now
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators |
| All Next | Launch Module |
Tenax Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Tenax Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Tenax Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Tenax to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0419 | |||
| Jensen Alpha | 0.1219 | |||
| Total Risk Alpha | 0.579 | |||
| Sortino Ratio | 0.0648 | |||
| Treynor Ratio | (0.65) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Tenax Stock Analysis
When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.